Results 191 to 200 of about 258,064 (337)

Portrait of a membrane protein in action: bacterio-rhodopsin pumping protons [PDF]

, 2000
K. A. P. Edman, Peter Nollert, Antoine Royant, Hassan Belrhali, Eva Pebay‐Peyroula, Thomas Ursby, Joseph Hajdu, Richard Neutze, Ehud M. Landau   +8 more
openalex   +1 more source

Mitochondrial Enzymes Mimetic Ultrasmall Palladium Nanozymes Prevent Senescence and Neurodegeneration Through Metabolic Reprogramming

Advanced Science, EarlyView.
Simply constructed polyvinylpyrrolidone (PVP) modified palladium nanoparticles (PdP NPs) as cytochrome c oxidase (CcO) and superoxide dismutase (SOD) mimic are promising multifunctional nanoreactors to boost mitochondrial respiration chain function and refine homeostasis via regulation of mitochondrial dynamics and proteostasis sensor UPRmt, which ...
Wenshu Cong, Haiming Jing, Zinan Li, Wenjing Zhang, Nan Zhang, Yingqiu Xie, Shan Gao, Yuanyu Huang, Junyu Ning   +8 more
wiley   +1 more source

Pharmacodynamic Modelling of Irreversible and Reversible Gastric Proton Pump Inhibitors

, 2003
Angela Äbelö
openalex   +1 more source

INB3P: A Multi‐Modal and Interpretable Co‐Attention Framework Integrating Property‐Aware Explanations and Memory‐Bank Contrastive Fusion for Blood–Brain Barrier Penetrating Peptide Discovery

Advanced Science, EarlyView.
INB3P is a multimodal framework for blood–brain barrier‐penetrating peptide prediction under extreme data scarcity and class imbalance. By combining physicochemical‐guided augmentation, sequence–structure co‐attention, and imbalance‐aware optimization, it improves predictive performance and interpretability.
Jingwei Lv, Qianyang Wu, Jian Liu, Binlu Yang, Yuanhao Li, Junlin Xu, Yajie Meng, Leyi Wei, Zilong Zhang, Quan Zou, Xiulai Li, Feifei Cui   +11 more
wiley   +1 more source

Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signatures. [PDF]

Cancer Immunol Immunother
Petouhoff A, Hicks R, Husain M, Hoyd R, Xu M, Dravillas C, Patel SH, Johns A, Grogan M, Li M, Lopez G, Miah A, Liu Y, Muniak M, Schmidt M, Das A, Lathrop H, Das P, Secor A, Haddad T, Tinoco G, Carbone D, Kendra K, Otterson GA, Presley CJ, Mace T, Spakowicz D, Owen DH.   +27 more
europepmc   +1 more source

Proton Translocating Property of Bacteriorhodopsin and a Stochastic Energization-Relaxation Channel Model. Essential Similarity and Distinction between Ion Pumps and Ion Channels.

, 1997
Eiro Muneyuki
openalex   +2 more sources

Multichannel intraluminal impedance (MII) in the evaluation of patients with persistent GERD symptoms despite proton pump inhibitors (PPI): A multicenter study [PDF]

, 2003
Steven S. Shay, Daniel Sifrim, Radu Țuțuian, Xin Zhang, Marcelo F. Vela, Donald O. Castell   +5 more
openalex   +1 more source

Crystal Facet‐Polysaccharide Matching in CFS‐P Nanocrystals Drives Fungal Uptake, Vacuole Destruction, and Selective Antifungal Activity

Advanced Science, EarlyView.
Facet‐engineered PVP‐capped CuFeSe2 nanocrystals exhibit potent, selective antifungal activity by strongly binding cell‐wall mannan, enabling vacuolar entry and organelle disruption. High‐index facets show superior mannan affinity, validated by theoretical calculations and experiments. CFS‐P induces vacuolar cavitation, mitochondrial abnormalities, and
Zhaohui Wang, Xiaojin Deng, Xujuan Huang, Yuhang Pan, Yao Qin, Lu Zhang, Le Xu, Tianyi Qin, Deteng Zhang, Yi Ma, Yalong Wang   +10 more
wiley   +1 more source

Proton Pump Inhibitors and Risk of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Almabruk BA, Alsulami GA, Alzahrani A, Alsulami EA, Badawood AA, Alghanim AS, Alresheedi FF, Alharbi RS, Alghamdi HA.   +8 more
europepmc   +1 more source

The Acid Test: Is Proton Pump Inhibitor Therapy an Independent Risk Factor for Clostridium difficile-Associated Disease? [PDF]

, 2007
Christina M. Surawicz
openalex   +1 more source